Enabling Subcutaneous Delivery for Improved Patient Compliance & Healthcare System Efficiencies
Summary: Nanoform Biologics’ high-dose subcutaneous delivery platform represents a significant…
Summary: Nanoform Biologics’ high-dose subcutaneous delivery platform represents a significant…
The increased complexity of many novel small molecules requires innovative…
High drug load formulations based on nanocrystals matching the performance…
Oral delivery remains the most common route of administration for…
The eye’s anatomical and physiological barriers protect against the entry…
The administration of topical pharmaceuticals to the respiratory tract is…
Atovaquone (Wellvone®, Mepron®), used to treat malaria, was successfully nanoformed.…
Whether to treat localised respiratory disease, or because the lung…